share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144：拟议出售证券

美股sec公告 ·  02/21 10:55
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 1,201 shares of common stock on 02/21/2024, with an aggregate market value of $506,545.77. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Morrow over the past three months, totaling 1,714 shares for gross proceeds of approximately $720,731.91.
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 1,201 shares of common stock on 02/21/2024, with an aggregate market value of $506,545.77. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Morrow over the past three months, totaling 1,714 shares for gross proceeds of approximately $720,731.91.
Vertex Pharmicals Inc.高管阿特金森·爱德华·莫罗三世定于2024年2月21日出售1,201股普通股，总市值为506,545.77美元。这些股票于2024年2月20日作为绩效股票收购，这是发行人的一种补偿形式。该交易遵循了莫罗在过去三个月中的近期销售记录，共计1,714股股票，总收益约为720,731.91美元。
Vertex Pharmicals Inc.高管阿特金森·爱德华·莫罗三世定于2024年2月21日出售1,201股普通股，总市值为506,545.77美元。这些股票于2024年2月20日作为绩效股票收购，这是发行人的一种补偿形式。该交易遵循了莫罗在过去三个月中的近期销售记录，共计1,714股股票，总收益约为720,731.91美元。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息